Page 1 - index
P. 1
|
Vol.1 Issue 2 The digital news magazine of RCM Enterprise Services, Inc. June 2018
Clearwater, FL
Position the Laboratory
85°F
for Molecular Testing NOW
Sunny with a chance
of thunderstorms
Sections:
—Featured article
—Editorial
—Trending
—Corporate report
—For the humor of it
—Tell us
Genetics market research
averages indicate market
expected growth to be
$27 billion by 2022 DNA sequencing has become a major factor in today’s growth in molecular
diagnostic (MDx) testing. It also plays an important role in Personalized Medicine, which
$27 billion is increasingly becoming the standard of care. Personalized Medicine utilizes
by 2022
the most effective approach—diagnostic, preventive, or therapeutic—to improve
a patient prognosis.
As the market continues to expand testing applications and newer technologies,
the overall demand will drive growth in the MDx field. MDx testing covers several key
$9.5 billion
in Sales areas and is not limited to one specific field. Genetic testing is used in blood screening,
2016
infectious disease diagnosis, oncology, and pharmacology.
Continued on page 02 
